OneDigital Investment Advisors LLC Acquires 961 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

OneDigital Investment Advisors LLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,798 shares of the company’s stock after purchasing an additional 961 shares during the period. OneDigital Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,295,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in GEHC. ING Groep NV acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at $2,973,000. Tokio Marine Asset Management Co. Ltd. grew its position in shares of GE HealthCare Technologies by 2.3% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 12,560 shares of the company’s stock worth $1,179,000 after buying an additional 286 shares during the period. Metis Global Partners LLC grew its holdings in GE HealthCare Technologies by 2.1% during the third quarter. Metis Global Partners LLC now owns 17,467 shares of the company’s stock valued at $1,639,000 after purchasing an additional 367 shares during the period. Schulhoff & Co. Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $201,000. Finally, KBC Group NV raised its position in shares of GE HealthCare Technologies by 179.0% during the third quarter. KBC Group NV now owns 184,258 shares of the company’s stock worth $17,292,000 after purchasing an additional 118,214 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

GEHC has been the topic of several research reports. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Wednesday, September 18th. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective for the company. Finally, UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $94.36.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Stock Up 1.2 %

Shares of NASDAQ GEHC opened at $82.72 on Tuesday. The firm has a fifty day simple moving average of $88.65 and a two-hundred day simple moving average of $83.55. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $37.79 billion, a PE ratio of 22.73, a price-to-earnings-growth ratio of 2.93 and a beta of 1.24. GE HealthCare Technologies Inc. has a 12 month low of $66.39 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter last year, the company earned $0.99 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.